Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
At 4mg/session weekly: ~2.5 sessions = ~0.6 months
Well, what did we find
Suzuki R, et al
In the recently published SELECT trial results, for example, semaglutide (marketed by Novo Nordisk as Wegovy for weight loss and Ozempic for type 2 diabetes) demonstrated a 20% risk reduction of heart attacks and strokes in overweight and obese individuals without diabetes and with cardiovascular disease, establishing it as a cardiovascular diseasemodifying medication in people without type 2 diabetes
Not all brands fortify equally, so its worth comparing labels to find those with higher B12 content
Early data appear promising, but ongoing medical monitoring is essential until larger research confirms extended outcomes
